Market capitalization | $3.45m |
Enterprise Value | $1.19m |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 0.72 |
P/S ratio (TTM) P/S ratio | 2.09 |
P/B ratio (TTM) P/B ratio | 0.93 |
Revenue growth (TTM) Revenue growth | 38.16% |
Revenue (TTM) Revenue | $1.65m |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
1 Analyst has issued a forecast SenesTech, Inc.:
1 Analyst has issued a forecast SenesTech, Inc.:
Sep '24 |
+/-
%
|
||
Revenue | 1.65 1.65 |
38%
38%
|
|
Gross Profit | 0.68 0.68 |
74%
74%
|
|
EBITDA | -6.58 -6.58 |
18%
18%
|
EBIT (Operating Income) EBIT | -6.73 -6.73 |
17%
17%
|
Net Profit | -6.66 -6.66 |
18%
18%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sector such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer in July 2004 and is headquartered in Phoenix, AZ.
Head office | United States |
CEO | Joel Fruendt |
Employees | 25 |
Founded | 2004 |
Website | www.senestech.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.